Ryan Spencer

Insider Reports History

Entity
Individual
Location
C/O Dynavax Technologies Corporation, 2929 Seventh Street, Suite 100, Berkeley, California
Signature
/s/ Shane Ward, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ryan Spencer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DYNAVAX TECHNOLOGIES CORP CEO and Director, Director Restricted Stock Unit 165 K $2.05 M $12.41 Feb 15, 2024 Direct
DYNAVAX TECHNOLOGIES CORP CEO and Director, Director Common Stock 201 K $1.9 M $9.45 Feb 15, 2024 Direct
DYNAVAX TECHNOLOGIES CORP CEO and Director, Director Stock Options (Right to Buy) 231 K Feb 15, 2024 Direct
Cidara Therapeutics, Inc. Director Stock Option (right to buy) 4.25 K Apr 26, 2024 Direct

Insider Reports Filed by Ryan Spencer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDTX Cidara Therapeutics, Inc. Apr 26, 2024 1 $0 4 Apr 30, 2024 Director
CDTX Cidara Therapeutics, Inc. Apr 24, 2024 0 $0 3 Apr 30, 2024 Director
DVAX DYNAVAX TECHNOLOGIES CORP Feb 15, 2024 3 $3.8 K 4 Feb 20, 2024 CEO and Director, Director
DVAX DYNAVAX TECHNOLOGIES CORP Feb 10, 2024 3 -$150 K 4 Feb 13, 2024 CEO and Director, Director
DVAX DYNAVAX TECHNOLOGIES CORP Feb 4, 2024 3 -$219 K 4 Feb 6, 2024 CEO and Director, Director
DVAX DYNAVAX TECHNOLOGIES CORP Feb 27, 2023 8 -$311 K 4 Mar 1, 2023 CEO and Director, Director
DVAX DYNAVAX TECHNOLOGIES CORP Feb 16, 2023 3 $34.5 K 4 Feb 21, 2023 CEO and Director, Director
DVAX DYNAVAX TECHNOLOGIES CORP Dec 9, 2022 1 $0 4 Dec 13, 2022 CEO and Director, Director
DVAX DYNAVAX TECHNOLOGIES CORP Aug 8, 2022 3 -$252 K 4 Aug 10, 2022 CEO and Director, Director
DVAX DYNAVAX TECHNOLOGIES CORP Mar 2, 2022 8 -$863 K 4 Mar 4, 2022 CEO and Director, Director
DVAX DYNAVAX TECHNOLOGIES CORP Feb 10, 2022 5 $6.67 K 4 Feb 14, 2022 CEO and Director, Director